Bio-Rad's $35M IP Win Tainted By Falsehoods, 10X Says
Bio-Rad Laboratories knowingly presented false testimony to a jury to extract a high licensing fee of 15% for DNA-manipulation patents, rival 10X Genomics told a Delaware federal court Friday in unusual...To view the full article, register now.
Already a subscriber? Click here to view full article